Francesca Maines

1.6k total citations
70 papers, 957 citations indexed

About

Francesca Maines is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Francesca Maines has authored 70 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 25 papers in Cancer Research and 24 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Francesca Maines's work include Prostate Cancer Treatment and Research (47 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Cancer, Lipids, and Metabolism (18 papers). Francesca Maines is often cited by papers focused on Prostate Cancer Treatment and Research (47 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Cancer, Lipids, and Metabolism (18 papers). Francesca Maines collaborates with scholars based in Italy, United Kingdom and Ukraine. Francesca Maines's co-authors include Orazio Caffo, Antonello Veccia, Francesco Massari, Giampaolo Tortora, Enzo Galligioni, Emilio Bria, Ugo De Giorgi, Gaetano Facchini, Stefania Kinspergher and Vincenza Conteduca and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Francesca Maines

62 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesca Maines Italy	18	642	350	300	216	193	70	957
Albertas Ulys Lithuania	16	1.1k 1.8×	323 0.9×	459 1.5×	282 1.3×	337 1.7×	64	1.4k
Giuseppe Schepisi Italy	18	441 0.7×	361 1.0×	264 0.9×	289 1.3×	108 0.6×	67	960
Mimma Rizzo Italy	17	696 1.1×	428 1.2×	333 1.1×	484 2.2×	98 0.5×	78	1.1k
Cristian Lolli Italy	19	761 1.2×	578 1.7×	331 1.1×	274 1.3×	141 0.7×	88	1.4k
Brian F. Chapin United States	22	1.5k 2.4×	406 1.2×	349 1.2×	345 1.6×	304 1.6×	116	1.9k
Dipesh Uprety United States	15	377 0.6×	484 1.4×	128 0.4×	313 1.4×	111 0.6×	71	1.0k
Valentina Bertaglia Italy	13	536 0.8×	417 1.2×	284 0.9×	142 0.7×	218 1.1×	36	905
Brandon Bernard United States	15	639 1.0×	225 0.6×	247 0.8×	275 1.3×	150 0.8×	39	992
Larysa Rydzewska United Kingdom	16	1.0k 1.6×	317 0.9×	181 0.6×	138 0.6×	377 2.0×	33	1.5k
Aranzazu González del Alba Spain	15	510 0.8×	274 0.8×	280 0.9×	359 1.7×	88 0.5×	79	870

Countries citing papers authored by Francesca Maines

Since Specialization

Citations

This map shows the geographic impact of Francesca Maines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Maines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Maines more than expected).

Fields of papers citing papers by Francesca Maines

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Maines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Maines. The network helps show where Francesca Maines may publish in the future.

Co-authorship network of co-authors of Francesca Maines

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Maines. A scholar is included among the top collaborators of Francesca Maines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Maines. Francesca Maines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maruzzo, Marco, Elena Verzoni, Giuseppe Procopio, et al.. (2024). Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney. Clinical Genitourinary Cancer. 22(5). 102186–102186. 1 indexed citations

Grasso, Margherita, Valerio Del Vescovo, Francesca Maines, et al.. (2024). Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study. International Journal of Molecular Sciences. 25(11). 5573–5573. 4 indexed citations

Iacovelli, Roberto, Chiara Ciccarese, Orazio Caffo, et al.. (2020). The prognostic value of pain in castration-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases. 23(4). 654–660. 10 indexed citations

Tucci, Marcello, Orazio Caffo, Consuelo Buttigliero, et al.. (2019). Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. Cancer Treatment Reviews. 74. 35–42. 22 indexed citations

Conteduca, Vincenza, Orazio Caffo, Luca Galli, et al.. (2018). Association among metabolic syndrome, inflammation, and survival in prostate cancer. Urologic Oncology Seminars and Original Investigations. 36(5). 240.e1–240.e11. 20 indexed citations

Claps, Mélanie, Fausto Petrelli, Orazio Caffo, et al.. (2018). Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis. Clinical Genitourinary Cancer. 16(3). 165–175.e2. 34 indexed citations

Conteduca, Vincenza, Orazio Caffo, Cristian Lolli, et al.. (2017). Long‐term clinical impact of PSA surge in castration‐resistant prostate cancer patients treated with abiraterone. The Prostate. 77(9). 1012–1019. 7 indexed citations

Passardi, Alessandro, Mimma Rizzo, Francesca Maines, et al.. (2017). Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility study. BMJ Open. 7(5). e014617–e014617. 22 indexed citations

Veccia, Antonello, Francesca Maines, Stefania Kinspergher, Enzo Galligioni, & Orazio Caffo. (2017). Cardiovascular toxicities of systemic treatments of prostate cancer. Nature Reviews Urology. 14(4). 230–243. 14 indexed citations

10.

Murgia, Viviana, Antonello Veccia, S. Brugnara, et al.. (2017). Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer. Anti-Cancer Drugs. 28(6). 654–659. 1 indexed citations

11.

Conteduca, Vincenza, Orazio Caffo, Luca Galli, et al.. (2017). Impact of metabolic syndrome on clinical outcome of castration resistant prostate cancer (CRPC) patients treated with abiraterone and enzalutamide. Annals of Oncology. 28. vi17–vi17. 1 indexed citations

12.

Caffo, Orazio, Elisa Biasco, Gaetano Facchini, et al.. (2016). Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study. Annals of Oncology. 27. vi252–vi252. 2 indexed citations

13.

Conteduca, Vincenza, Simon J. Crabb, Robert J. Jones, et al.. (2016). Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer. PLoS ONE. 11(7). e0158952–e0158952. 42 indexed citations

14.

Caffo, Orazio, Francesca Maines, Mimma Rizzo, Stefania Kinspergher, & Antonello Veccia. (2016). Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions. Clinical Interventions in Aging. Volume 12. 19–28. 9 indexed citations

15.

Caffo, Orazio, Francesca Maines, Antonello Veccia, Stefania Kinspergher, & Enzo Galligioni. (2016). Splice variants of androgen receptor and prostate cancer. Oncology Reviews. 10(1). 297–297. 5 indexed citations

16.

Massari, Francesco, Alessandra Modena, Chiara Ciccarese, et al.. (2015). Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials.. Critical Reviews in Oncology/Hematology. 98. 254–263.

17.

Galligioni, Enzo, Enrico Maria Piras, Claudio Eccher, et al.. (2015). Integrating mHealth in Oncology: Experience in the Province of Trento. Journal of Medical Internet Research. 17(5). e114–e114. 35 indexed citations

18.

Veccia, Antonello, Orazio Caffo, G. Fellin, et al.. (2015). Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study. Radiation Oncology. 10(1). 130–130. 5 indexed citations

19.

Buti, Sebastiano, Melissa Bersanelli, Francesca Maines, et al.. (2013). Chemotherapy in metastatic renal cell carcinoma today? A systematic review. Anti-Cancer Drugs. 24(6). 535–554. 69 indexed citations

20.

Massari, Francesco, Francesca Maines, Alessandra Modena, et al.. (2013). Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges. Anti-Cancer Agents in Medicinal Chemistry. 13(6). 872–886. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact